The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: Implications for hypertension management

被引:9
作者
Lim, Hoong Sern [1 ]
MacFadyen, Robert J. [1 ]
Bakris, George [1 ]
Lip, Gregory Y. H. [1 ]
机构
[1] Univ Birmingham Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
关键词
diabetes; endothelium; glucose; insulin resistance; thrombosis;
D O I
10.2174/138161206776843322
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Population studies have identified diabetes mellitus as a risk factor for cardiac and vascular events, with a common association with hypertension. Observational studies have consistently demonstrated blood glucose as a continuous cardiovascular risk factor. Experimental studies suggest that elevated blood glucose, through a range of biochemical pathways can promote atherogenesis and increase the tendency for thrombosis. The resultant state promotes occlusion of arterial flow and increase cardiovascular event rates. However, an unconvincing temporal relationship (raised blood glucose preceding cardiovascular events) and the limited impact of glucose reduction in patients with diabetes on cardiovascular events do not support blood glucose as a major cause of cardiovascular disease. In this review, we discuss the relationship between hyperglycaemia and a hypercoagulable state in diabetes and the implications of this relationship for the treatment of patients with diabetes, who also commonly have hypertension.
引用
收藏
页码:1567 / 1579
页数:13
相关论文
共 143 条
[21]  
Ceriello A, 2000, DIABETES-METAB RES, V16, P125, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<125::AID-DMRR90>3.0.CO
[22]  
2-4
[23]   Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation - Effects of short- and long-term simvastatin treatment [J].
Ceriello, A ;
Taboga, C ;
Tonutti, L ;
Quagliaro, L ;
Piconi, L ;
Bais, B ;
Da Ros, R ;
Motz, E .
CIRCULATION, 2002, 106 (10) :1211-1218
[24]   INCREASED SERUM CONCENTRATION OF VON-WILLEBRAND-FACTOR IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS WITH AND WITHOUT DIABETIC NEPHROPATHY [J].
CHEN, JW ;
GALL, MA ;
DECKERT, M ;
JENSEN, JS ;
PARVING, HH .
BRITISH MEDICAL JOURNAL, 1995, 311 (7017) :1405-1406
[25]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[26]  
COLLIER A, 1989, DIABETES METAB, V15, P420
[27]  
Collins R, 2003, LANCET, V361, P2005
[28]  
Colwell John A, 2003, Diabetes Care, V26 Suppl 1, pS87
[29]   The relationship between glucose and incident cardiovascular events [J].
Coutinho, M ;
Gerstein, HC ;
Wang, Y ;
Yusuf, S .
DIABETES CARE, 1999, 22 (02) :233-240
[30]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482